Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Rani Therapeutics Holdings (RANI)
NASDAQ:RANI
Rani Therapeutics Holdings (RANI) Stock Price & Analysis
34 Followers
RANI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.92 - $14.90
Previous Close$5.44
Volume26.13K
Average Volume (3M)31.76K
Market Cap
$265.67M
Enterprise Value$234.55M
Total Cash (Recent Filing)$98.48M
Total Debt (Recent Filing)$30.21M
Price to Earnings (P/E)-4.2
Beta0.36
Next Earnings
May 10, 2023EPS Estimate
-$0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.28
Shares Outstanding25,295,159
10 Day Avg. Volume23,809
30 Day Avg. Volume31,757
Standard Deviation0.28
R-Squared0.00969
Alpha0.00908
Financial Highlights & Ratios
Price to Book (P/B)3.71
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.80
Forecast
1Y Price Target
$22.00Price Target Upside305.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Rani Therapeutics Holdings News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Number of people who visit Rani Therapeutics Holdings websites
Desktop Users
Mobile Users
RANI FAQ
What was Rani Therapeutics Holdings’s price range in the past 12 months?
Rani Therapeutics Holdings lowest stock price was $4.92 and its highest was $14.90 in the past 12 months.
What is Rani Therapeutics Holdings’s market cap?
Currently, no data Available
When is Rani Therapeutics Holdings’s upcoming earnings report date?
Rani Therapeutics Holdings’s upcoming earnings report date is May 10, 2023 which is in 42 days.
How were Rani Therapeutics Holdings’s earnings last quarter?
Rani Therapeutics Holdings released its earnings results on Mar 22, 2023. The company reported -$0.35 earnings per share for the quarter, beating the consensus estimate of -$0.401 by $0.051.
Is Rani Therapeutics Holdings overvalued?
According to Wall Street analysts Rani Therapeutics Holdings’s price is currently Undervalued.
Does Rani Therapeutics Holdings pay dividends?
Rani Therapeutics Holdings does not currently pay dividends.
What is Rani Therapeutics Holdings’s EPS estimate?
Rani Therapeutics Holdings’s EPS estimate is -$0.47.
How many shares outstanding does Rani Therapeutics Holdings have?
Rani Therapeutics Holdings has 24,719,973 shares outstanding.
What happened to Rani Therapeutics Holdings’s price movement after its last earnings report?
Rani Therapeutics Holdings reported an EPS of -$0.35 in its last earnings report, beating expectations of -$0.401. Following the earnings report the stock price went down -6.891%.
Which hedge fund is a major shareholder of Rani Therapeutics Holdings?
Currently, no hedge funds are holding shares in RANI
---
Rani Therapeutics Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$22.00 (305.16% Upside)
$22.00 (305.16% Upside)
Insider Transactions
Bought Shares
Worth $622.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-60.91%
12-Months-Change
Fundamentals
Return on Equity
-72.60%
Trailing 12-Months
Asset Growth
-13.03%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Rani Therapeutics Holdings
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. It has developed the RaniPill capsule, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.
---
Top 5 ETFs holding RANI
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold RANI. The ETFs are listed according to market value of RANI within the ETF
---
---